Skip to main content

COVID-19 vaccine sales push Cambridge-based Moderna to $12B profit in 2021

By WBUR  
   February 25, 2022

COVID-19 vaccine sales jumped 44% for Moderna in the final quarter of 2021, and the drugmaker expects demand for booster shots to fuel more growth in 2022.

Full story


Get the latest on healthcare leadership in your inbox.